163 related articles for article (PubMed ID: 7541296)
1. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies.
Malle E; Hazell L; Stocker R; Sattler W; Esterbauer H; Waeg G
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):982-9. PubMed ID: 7541296
[TBL] [Abstract][Full Text] [Related]
2. Immunological evidence for hypochlorite-modified proteins in human kidney.
Malle E; Woenckhaus C; Waeg G; Esterbauer H; Gröne EF; Gröne HJ
Am J Pathol; 1997 Feb; 150(2):603-15. PubMed ID: 9033274
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
[TBL] [Abstract][Full Text] [Related]
4. Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Hazell LJ; Arnold L; Flowers D; Waeg G; Malle E; Stocker R
J Clin Invest; 1996 Mar; 97(6):1535-44. PubMed ID: 8617887
[TBL] [Abstract][Full Text] [Related]
5. Hypochlorite-modified low-density lipoprotein induces the apoptotic machinery in Jurkat T-cell lines.
Resch U; Semlitsch M; Hammer A; Susani-Etzerodt H; Walczak H; Sattler W; Malle E
Biochem Biophys Res Commun; 2011 Jul; 410(4):895-900. PubMed ID: 21708126
[TBL] [Abstract][Full Text] [Related]
6. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
Palinski W; Ylä-Herttuala S; Rosenfeld ME; Butler SW; Socher SA; Parthasarathy S; Curtiss LK; Witztum JL
Arteriosclerosis; 1990; 10(3):325-35. PubMed ID: 1693068
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo.
Tsimikas S; Palinski W; Halpern SE; Yeung DW; Curtiss LK; Witztum JL
J Nucl Cardiol; 1999; 6(1 Pt 1):41-53. PubMed ID: 10070840
[TBL] [Abstract][Full Text] [Related]
8. Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins.
Hammer A; Kager G; Dohr G; Rabl H; Ghassempur I; Jürgens G
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):704-13. PubMed ID: 7749884
[TBL] [Abstract][Full Text] [Related]
9. The IgM response to modified LDL in experimental atherosclerosis: hypochlorite-modified LDL IgM antibodies versus classical natural T15 IgM antibodies.
van Leeuwen M; Damoiseaux J; Duijvestijn A; Heeringa P; Gijbels M; de Winther M; Tervaert JW
Ann N Y Acad Sci; 2009 Sep; 1173():274-9. PubMed ID: 19758162
[TBL] [Abstract][Full Text] [Related]
10. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination.
Chen Q; Esterbauer H; Jürgens G
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):249-54. PubMed ID: 1280111
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.
Boyd HC; Gown AM; Wolfbauer G; Chait A
Am J Pathol; 1989 Nov; 135(5):815-25. PubMed ID: 2683796
[TBL] [Abstract][Full Text] [Related]
12. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
Jerlich A; Fabjan JS; Tschabuschnig S; Smirnova AV; Horakova L; Hayn M; Auer H; Guttenberger H; Leis HJ; Tatzber F; Waeg G; Schaur RJ
Free Radic Biol Med; 1998 May; 24(7-8):1139-48. PubMed ID: 9626568
[TBL] [Abstract][Full Text] [Related]
13. Human neutrophils oxidize low-density lipoprotein by a hypochlorous acid-dependent mechanism: the role of vitamin C.
Carr AC; Frei B
Biol Chem; 2002; 383(3-4):627-36. PubMed ID: 12033452
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions.
Moguilevsky N; Zouaoui Boudjeltia K; Babar S; Delrée P; Legssyer I; Carpentier Y; Vanhaeverbeek M; Ducobu J
Biochem Biophys Res Commun; 2004 Oct; 323(4):1223-8. PubMed ID: 15451427
[TBL] [Abstract][Full Text] [Related]
15. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins.
Hazell LJ; Davies MJ; Stocker R
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):489-95. PubMed ID: 10215584
[TBL] [Abstract][Full Text] [Related]
16. Products of the reaction of HOCl with tryptophan protect LDL from atherogenic modification.
Kapiotis S; Jirovetz L; Hermann M; Laggner H; Exner M; Esterbauer H; Gmeiner BM
Biochimie; 2006 Jul; 88(7):785-91. PubMed ID: 16488068
[TBL] [Abstract][Full Text] [Related]
17. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
[TBL] [Abstract][Full Text] [Related]
18. (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins.
Kaur K; Salomon RG; O'Neil J; Hoff HF
Chem Res Toxicol; 1997 Dec; 10(12):1387-96. PubMed ID: 9437530
[TBL] [Abstract][Full Text] [Related]
19. Generation of intramolecular and intermolecular sulfenamides, sulfinamides, and sulfonamides by hypochlorous acid: a potential pathway for oxidative cross-linking of low-density lipoprotein by myeloperoxidase.
Fu X; Mueller DM; Heinecke JW
Biochemistry; 2002 Jan; 41(4):1293-301. PubMed ID: 11802729
[TBL] [Abstract][Full Text] [Related]
20. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.
Ylä-Herttuala S; Palinski W; Butler SW; Picard S; Steinberg D; Witztum JL
Arterioscler Thromb; 1994 Jan; 14(1):32-40. PubMed ID: 7506053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
